Clindamycin Phosphate And Benzoyl Peroxide Kit
NDC Package 51672-1381-2
Package Information
Clindamycin Phosphate And Benzoyl Peroxide (clindamycin and benzoyl peroxide gel) kits is clindamycin and Benzoyl Peroxide Gel, 1%/5% is indicated for the topical treatment of acne vulgaris. This formulation utilizes a kit delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-1381 and is authorized under FDA application ANDA208776.
Identification & Billing
- RxCUI: 308694 - benzoyl peroxide 5 % Topical Gel
- RxCUI: 308694 - benzoyl peroxide 0.05 MG/MG Topical Gel
- RxCUI: 309333 - clindamycin phosphate 1 % Topical Solution
- RxCUI: 309333 - clindamycin 10 MG/ML Topical Solution
- RxCUI: 309333 - clindamycin (as clindamycin phosphate) 1 % Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-1381 - Clindamycin Phosphate And Benzoyl Peroxide
- 51672-1381-2 - 1 KIT in 1 CARTON * 5 g in 1 BOTTLE, PLASTIC (51672-1382-1) * 20 g in 1 JAR
- 51672-1381 - Clindamycin Phosphate And Benzoyl Peroxide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-1381). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-1381-2 identifies a specific commercial package of 1 kit in 1 carton * 5 g in 1 bottle, plastic (51672-1382-1) * 20 g in 1 jar of Clindamycin Phosphate And Benzoyl Peroxide, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on January 21, 2020. The current certification is valid through December 31, 2026.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672138102. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.